A phase II trial of cabozantinib (Cabo) in patients (pts) with castrate-resistant prostate cancer (CRPC) metastatic to bone (NCT01428219)
Grivas, Petros, Daignault, Stephanie, Cooney, Kathleen A., Jacobson, Jon, Yablon, Corrie, Ross, Brian Dale, Chenevert, Thomas L, Galbán, Craig J, Rehemtulla, Alnawaz, Keller, Evan T., Kunju, Priya, Mehra, Rohit, Escara-Wilke, June, Shelley, Greg, Pienta, Kenneth James, Hussain, Maha, Smith, David C.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
METHODS TO DIAGNOSE, DETECT, OR ASSESS CANCER USING ISOTOPIC ELEMENTAL ANALYSIS
UDDIN, Kazi Julhash, HAMMARLUND, Emma Ulrika, PIENTA, Kenneth James, MALMBERG, Per Kristian
Year of Publication 22.08.2024
Get full text
Year of Publication 22.08.2024
Patent